Efficacy of pulsed dye laser plus topical tazarotene versus topical tazarotene alone in psoriatic nail disease: A single-blind, intrapatient left-to-right controlled study

Lasers in Surgery and Medicine

Volumn 45, Issue 2, 2013, Pages 102-107

  Huang, Yu Chen ^a   Chou, Chia Lun ^b   Chiang, Ying Yi ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

psoriasis; psoriatic nail; pulsed dye laser; tazarotene

Indexed keywords

TAZAROTENE;

ADULT; APPLICATION SITE VESICLE; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL THERAPY; FEMALE; HUMAN; MALE; NAIL PSORIASIS; PHOTOTHERAPY; PRIORITY JOURNAL; PULSED DYE LASER; SYSTEMIC THERAPY;

ADMINISTRATION, TOPICAL; ADULT; AGED; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LASERS, DYE; MALE; MIDDLE AGED; NAIL DISEASES; NICOTINIC ACIDS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 84874452930     PISSN: 01968092     EISSN: 10969101     Source Type: Journal    
DOI: 10.1002/lsm.22122     Document Type: Article

References (13)

1. Salomon J, Szepietowski JC, Proniewick A,. Psoriatic nails: A prospective clinical study. J Cutan Med Surg 2003; 7: 317-321.
2. De Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC,. Psoriasis of the nails associated with disability in a large number of patients: Results of a recent interview with 1. 728 patients. Dermatology 1996; 193: 300-303.
3. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY,. Psoriasis of the nail: Anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27.
4. Lawry M,. Biological therapy nail psoriasis. Dermatol Ther 2007; 20: 60-67.
5. Erceg A, Bovenschen HJ, van de Kerkhof PC, Seyger MM,. Efficacy of the pulsed dye laser in the treatment of localized recalcitrant plaque psoriasis: A comparative study. Br J Dermatol 2006; 155: 110-114.
6. Fernandez-Guarino M, Harto A, Sanchez-Ronco M, García-Morales I, Jaén P,. Pulsed dye laser vs. photodynamic therapy in the treatment of refractory nail psoriasis: A comparative pilot study. J Eur Acad Dermatol Venereol 2009; 23: 891-895.
7. Oram Y, Karincaoglu Y, Koyuncu E, Kaharaman F,. Pulsed dye laser in the treatment of nail psoriasis. Dermatol Surg 2010; 36: 377-381.
8. Treewittayapoom C, Singvahanont P, Chanprapaph K, Haneke E,. The effect of different pulse durations in the treatment of nail psoriasis with 595-nm pulsed dye laser: A randomized, double-blind, intrapatient left-to-right study. J Am Acad Dermatol 2012; 66: 807-812.
9. Bianchi L, Soda R, Diluvio L, Chimenti S,. Tazarotene 0.1% gel for psoriasis of the fingernails and toenails: An open, prospective study. Br J Dermatol 2003; 149: 207-209.
10. Rigopoulos D, Gregoriou S, Katsambas A,. Treatment of psoriatic nails with tazarotene cream 0.1% vs. clobetasol propionate 0.05% cream: A double-blind study. Acta Derm Venereol 2007; 87: 167-168.
11. Scher RK, Stiller M, Zhu YI,. Tazarotene 0.1% gel in the treatment of fingernail psoriasis: A double-blind, randomized, vehicle-controlled study. Cutis 2001; 68: 355-358.
12. Duvic M,. Pharmacologic profile of tazarotene. Cutis 1998; 61: 22-26.
13. Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A,. The modified Nail Psoriasis Severity Index: Validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007; 34: 123-129.